Cargando…

Clinical significance of p16(INK4A) and p14(ARF) promoter methylation in renal cell carcinoma: a meta-analysis

The inactivation of p16(INK4A) and p14(ARF) via promoter methylation has been investigated in various cancers. However, the clinical effects of p16(INK4A) and p14(ARF) promoter methylation on renal cell carcinoma (RCC) remain to be clarified. The pooled data were calculated and summarized. Finally,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yu, Xiao, Li, Weng, Guobin, Shi, Bingyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610010/
https://www.ncbi.nlm.nih.gov/pubmed/28969078
http://dx.doi.org/10.18632/oncotarget.18826
_version_ 1783265710382776320
author Ren, Yu
Xiao, Li
Weng, Guobin
Shi, Bingyi
author_facet Ren, Yu
Xiao, Li
Weng, Guobin
Shi, Bingyi
author_sort Ren, Yu
collection PubMed
description The inactivation of p16(INK4A) and p14(ARF) via promoter methylation has been investigated in various cancers. However, the clinical effects of p16(INK4A) and p14(ARF) promoter methylation on renal cell carcinoma (RCC) remain to be clarified. The pooled data were calculated and summarized. Finally, an investigation of 14 eligible studies with 1231 RCC patients and 689 control patients was performed. Methylated p16(INK4A) and p14(ARF) were observed to be significantly higher in RCC than in control subjects without malignancies (OR = 2.77, P = 0.005; OR = 11.73, P < 0.001, respectively). Methylated p16(INK4A) was significantly associated with the risk of RCC in the tissue subgroup, but not in the serum and urine subgroups. Methylated p16(INK4A) was significantly associated with tumor size. We did not find that p16(INK4A) promoter methylation was associated with sex, tumor grade, lymph node status, and tumor histology. Methylated p14(ARF) was significantly correlated with sex and tumor histology. Three studies reported that p16(INK4A) methylation was not significantly correlated with the prognosis of RCC. The results suggested that p16(INK4A) and p14(ARF) promoter methylation may be correlated with the carcinogenesis of RCC, and that methylated p14(ARF), especially, can be a major susceptibility gene. We also found the different clinicopathological significance of 16(INK4A) and p14(ARF) in RCC. Additional studies with sufficient data are essential to further evaluate the clinical features and prognostic effect of p16(INK4A) and p14(ARF) promoter methylation in RCC.
format Online
Article
Text
id pubmed-5610010
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56100102017-09-29 Clinical significance of p16(INK4A) and p14(ARF) promoter methylation in renal cell carcinoma: a meta-analysis Ren, Yu Xiao, Li Weng, Guobin Shi, Bingyi Oncotarget Meta-Analysis The inactivation of p16(INK4A) and p14(ARF) via promoter methylation has been investigated in various cancers. However, the clinical effects of p16(INK4A) and p14(ARF) promoter methylation on renal cell carcinoma (RCC) remain to be clarified. The pooled data were calculated and summarized. Finally, an investigation of 14 eligible studies with 1231 RCC patients and 689 control patients was performed. Methylated p16(INK4A) and p14(ARF) were observed to be significantly higher in RCC than in control subjects without malignancies (OR = 2.77, P = 0.005; OR = 11.73, P < 0.001, respectively). Methylated p16(INK4A) was significantly associated with the risk of RCC in the tissue subgroup, but not in the serum and urine subgroups. Methylated p16(INK4A) was significantly associated with tumor size. We did not find that p16(INK4A) promoter methylation was associated with sex, tumor grade, lymph node status, and tumor histology. Methylated p14(ARF) was significantly correlated with sex and tumor histology. Three studies reported that p16(INK4A) methylation was not significantly correlated with the prognosis of RCC. The results suggested that p16(INK4A) and p14(ARF) promoter methylation may be correlated with the carcinogenesis of RCC, and that methylated p14(ARF), especially, can be a major susceptibility gene. We also found the different clinicopathological significance of 16(INK4A) and p14(ARF) in RCC. Additional studies with sufficient data are essential to further evaluate the clinical features and prognostic effect of p16(INK4A) and p14(ARF) promoter methylation in RCC. Impact Journals LLC 2017-06-28 /pmc/articles/PMC5610010/ /pubmed/28969078 http://dx.doi.org/10.18632/oncotarget.18826 Text en Copyright: © 2017 Ren et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Meta-Analysis
Ren, Yu
Xiao, Li
Weng, Guobin
Shi, Bingyi
Clinical significance of p16(INK4A) and p14(ARF) promoter methylation in renal cell carcinoma: a meta-analysis
title Clinical significance of p16(INK4A) and p14(ARF) promoter methylation in renal cell carcinoma: a meta-analysis
title_full Clinical significance of p16(INK4A) and p14(ARF) promoter methylation in renal cell carcinoma: a meta-analysis
title_fullStr Clinical significance of p16(INK4A) and p14(ARF) promoter methylation in renal cell carcinoma: a meta-analysis
title_full_unstemmed Clinical significance of p16(INK4A) and p14(ARF) promoter methylation in renal cell carcinoma: a meta-analysis
title_short Clinical significance of p16(INK4A) and p14(ARF) promoter methylation in renal cell carcinoma: a meta-analysis
title_sort clinical significance of p16(ink4a) and p14(arf) promoter methylation in renal cell carcinoma: a meta-analysis
topic Meta-Analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610010/
https://www.ncbi.nlm.nih.gov/pubmed/28969078
http://dx.doi.org/10.18632/oncotarget.18826
work_keys_str_mv AT renyu clinicalsignificanceofp16ink4aandp14arfpromotermethylationinrenalcellcarcinomaametaanalysis
AT xiaoli clinicalsignificanceofp16ink4aandp14arfpromotermethylationinrenalcellcarcinomaametaanalysis
AT wengguobin clinicalsignificanceofp16ink4aandp14arfpromotermethylationinrenalcellcarcinomaametaanalysis
AT shibingyi clinicalsignificanceofp16ink4aandp14arfpromotermethylationinrenalcellcarcinomaametaanalysis